GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 233 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q4 2020. The put-call ratio across all filers is 1.21 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $1,915,000 | +198.3% | 28,111 | +39.9% | 0.01% | +150.0% |
| Q2 2022 | $642,000 | +191.8% | 20,097 | +132.9% | 0.00% | +100.0% |
| Q3 2021 | $220,000 | -23.3% | 8,630 | +5.4% | 0.00% | 0.0% |
| Q2 2021 | $287,000 | -13.8% | 8,189 | +0.3% | 0.00% | 0.0% |
| Q1 2021 | $333,000 | -6.7% | 8,168 | -0.9% | 0.00% | 0.0% |
| Q4 2020 | $357,000 | -23.1% | 8,243 | -2.0% | 0.00% | -50.0% |
| Q3 2020 | $464,000 | -5.7% | 8,415 | +8.0% | 0.00% | -33.3% |
| Q2 2020 | $492,000 | +10.1% | 7,793 | -11.0% | 0.00% | 0.0% |
| Q1 2020 | $447,000 | -58.7% | 8,754 | -63.4% | 0.00% | -80.0% |
| Q2 2018 | $1,082,000 | +116.8% | 23,939 | +48.9% | 0.02% | +66.7% |
| Q3 2017 | $499,000 | – | 16,082 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alerce Investment Management, L.P. | 356,270 | $24,262,000 | 23.36% |
| Twin Securities, Inc. | 376,669 | $25,651,000 | 11.94% |
| Paradigm Biocapital Advisors LP | 1,175,879 | $80,077,000 | 10.68% |
| Chicago Capital Management, LLC | 246,246 | $16,769,000 | 9.12% |
| HARVEST MANAGEMENT LLC | 141,500 | $9,636,000 | 7.78% |
| Fernwood Investment Management, LLC | 174,724 | $11,899,000 | 5.02% |
| ArchPoint Investors | 168,725 | $11,490,000 | 4.69% |
| HAVENS ADVISORS LLC | 46,000 | $3,133,000 | 4.69% |
| Perceptive Advisors | 2,322,247 | $158,145,000 | 4.59% |
| Crabel Capital Management, LLC | 112,680 | $7,674,000 | 4.48% |